Chemical Compound Review:
Cytovene 2-amino-9-(1,3- dihydroxypropan-2...
Synonyms:
Cymevene, Citovirax, Cymevan, Cymeven, Gancyclovir, ...
- Oral ganciclovir as prophylaxis against cytomegalovirus. Pulido, F., Carnevali, D., Rubio, R. N. Engl. J. Med. (1996)
- The relationship of IL-4- and IFN gamma-producing T cells studied by lineage ablation of IL-4-producing cells. Kamogawa, Y., Minasi, L.A., Carding, S.R., Bottomly, K., Flavell, R.A. Cell (1993)
- Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group. Martin, D.F., Kuppermann, B.D., Wolitz, R.A., Palestine, A.G., Li, H., Robinson, C.A. N. Engl. J. Med. (1999)
- Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation. Goodrich, J.M., Mori, M., Gleaves, C.A., Du Mond, C., Cays, M., Ebeling, D.F., Buhles, W.C., DeArmond, B., Meyers, J.D. N. Engl. J. Med. (1991)
- The use of oral ganciclovir in the treatment of cytomegalovirus retinitis in patients with AIDS. Ward-Able, C., Phillips, P., Tsoukas, C.M. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. (1996)
- Psychiatric disturbances associated with ganciclovir therapy. Chen, J.L., Brocavich, J.M., Lin, A.Y. The Annals of pharmacotherapy. (1992)
- Pharmacokinetics of antiviral agents for the treatment of cytomegalovirus infection. Baillie, G.M. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. (2005)
- Efficacy of oral ganciclovir in prevention of cytomegalovirus infection in post-kidney transplant patients. Ahsan, N., Holman, M.J., Yang, H.C. Clinical transplantation. (1997)
- Fulminant jejuno-ileitis following ablation of enteric glia in adult transgenic mice. Bush, T.G., Savidge, T.C., Freeman, T.C., Cox, H.J., Campbell, E.A., Mucke, L., Johnson, M.H., Sofroniew, M.V. Cell (1998)
- Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS. Roche Cooperative Oral Ganciclovir Study Group. Spector, S.A., McKinley, G.F., Lalezari, J.P., Samo, T., Andruczk, R., Follansbee, S., Sparti, P.D., Havlir, D.V., Simpson, G., Buhles, W., Wong, R., Stempien, M. N. Engl. J. Med. (1996)
- Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. Syntex Cooperative Oral Ganciclovir Study Group. Drew, W.L., Ives, D., Lalezari, J.P., Crumpacker, C., Follansbee, S.E., Spector, S.A., Benson, C.A., Friedberg, D.N., Hubbard, L., Stempien, M.J. N. Engl. J. Med. (1995)
- Human cytomegalovirus UL97 open reading frame encodes a protein that phosphorylates the antiviral nucleoside analogue ganciclovir. Littler, E., Stuart, A.D., Chee, M.S. Nature (1992)
- Acyclovir and ganciclovir in cytomegalovirus. Moss, G.B. Ann. Intern. Med. (1994)
- Toxicity of combined ganciclovir and zidovudine for cytomegalovirus disease associated with AIDS. An AIDS Clinical Trials Group Study. Hochster, H., Dieterich, D., Bozzette, S., Reichman, R.C., Connor, J.D., Liebes, L., Sonke, R.L., Spector, S.A., Valentine, F., Pettinelli, C. Ann. Intern. Med. (1990)
- Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Chen, S.H., Shine, H.D., Goodman, J.C., Grossman, R.G., Woo, S.L. Proc. Natl. Acad. Sci. U.S.A. (1994)
- Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients. Erice, A., Chou, S., Biron, K.K., Stanat, S.C., Balfour, H.H., Jordan, M.C. N. Engl. J. Med. (1989)
- A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells. Sullivan, V., Talarico, C.L., Stanat, S.C., Davis, M., Coen, D.M., Biron, K.K. Nature (1992)
- Epstein-Barr virus-driven gene therapy for EBV-related lymphomas. Franken, M., Estabrooks, A., Cavacini, L., Sherburne, B., Wang, F., Scadden, D.T. Nat. Med. (1996)
- Suppression of erythro-megakaryocytopoiesis and the induction of reversible thrombocytopenia in mice transgenic for the thymidine kinase gene targeted by the platelet glycoprotein alpha IIb promoter. Tronik-Le Roux, D., Roullot, V., Schweitzer, A., Berthier, R., Marguerie, G. J. Exp. Med. (1995)
- A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants; The City of Hope-Stanford-Syntex CMV Study Group. Schmidt, G.M., Horak, D.A., Niland, J.C., Duncan, S.R., Forman, S.J., Zaia, J.A. N. Engl. J. Med. (1991)
- Central nervous system side effects of ganciclovir. Davis, C.L., Springmeyer, S., Gmerek, B.J. N. Engl. J. Med. (1990)
- Restoration of cytomegalovirus-specific CD4+ T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1. Komanduri, K.V., Viswanathan, M.N., Wieder, E.D., Schmidt, D.K., Bredt, B.M., Jacobson, M.A., McCune, J.M. Nat. Med. (1998)
- A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells. Sullivan, V., Talarico, C.L., Stanat, S.C., Davis, M., Coen, D.M., Biron, K.K. Nature (1992)
- Re: Synergistic anticancer effects of ganciclovir/thymidine kinase and 5-fluorocytosine/cytosine deaminase gene therapies. Liao, W.C., Chang, W.S., Wu, F.Y. J. Natl. Cancer Inst. (1999)
- Inhibition of immune functions by antiviral drugs. Heagy, W., Crumpacker, C., Lopez, P.A., Finberg, R.W. J. Clin. Invest. (1991)
- Transactivation of the metallothionein promoter in cisplatin-resistant cancer cells: a specific gene therapy strategy. Vandier, D., Calvez, V., Massade, L., Gouyette, A., Mickley, L., Fojo, T., Rixe, O. J. Natl. Cancer Inst. (2000)
- Optimal management of the post-intestinal transplant patient. Horslen, S.P. Gastroenterology (2006)
- Involvement of proteasome alpha-subunit PSMA7 in hepatitis C virus internal ribosome entry site-mediated translation. Krüger, M., Beger, C., Welch, P.J., Barber, J.R., Manns, M.P., Wong-Staal, F. Mol. Cell. Biol. (2001)
- Replication of an adenoviral vector controlled by the human telomerase reverse transcriptase promoter causes tumor-selective tumor lysis. Lanson, N.A., Friedlander, P.L., Schwarzenberger, P., Kolls, J.K., Wang, G. Cancer Res. (2003)
- Targeted ablation of secretin-producing cells in transgenic mice reveals a common differentiation pathway with multiple enteroendocrine cell lineages in the small intestine. Rindi, G., Ratineau, C., Ronco, A., Candusso, M.E., Tsai, M., Leiter, A.B. Development (1999)
- Human cytomegalovirus infection decreases expression of thrombospondin-1 independent of the tumor suppressor protein p53. Cinatl, J., Kotchetkov, R., Scholz, M., Cinatl, J., Vogel, J.U., Driever, P.H., Doerr, H.W. Am. J. Pathol. (1999)
- The suppression of colon cancer cell growth in nude mice by targeting beta-catenin/TCF pathway. Kwong, K.Y., Zou, Y., Day, C.P., Hung, M.C. Oncogene (2002)
- A controlled trial of ganciclovir to prevent cytomegalovirus disease after heart transplantation. Merigan, T.C., Renlund, D.G., Keay, S., Bristow, M.R., Starnes, V., O'Connell, J.B., Resta, S., Dunn, D., Gamberg, P., Ratkovec, R.M. N. Engl. J. Med. (1992)
- Experimental autoimmune encephalomyelitis repressed by microglial paralysis. Heppner, F.L., Greter, M., Marino, D., Falsig, J., Raivich, G., Hövelmeyer, N., Waisman, A., Rülicke, T., Prinz, M., Priller, J., Becher, B., Aguzzi, A. Nat. Med. (2005)